Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays

被引:45
作者
Kavanagh, Angela [1 ]
Ramu, Soumya [1 ]
Gong, Yujing [1 ]
Cooper, Matthew A. [1 ]
Blaskovich, Mark A. T. [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia
基金
英国惠康基金; 澳大利亚国家健康与医学研究理事会;
关键词
MIC; additive effects; broth microdilution assay; microtiter plate effects; SERUM-PROTEIN BINDING; ACINETOBACTER-BAUMANNII; STAPHYLOCOCCUS-AUREUS; CONTROL STRAINS; POLYMYXIN-B; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; BACTERICIDAL ACTIVITY; ESCHERICHIA-COLI; TESTING METHODS;
D O I
10.1128/AAC.01760-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The determination of antibiotic potency against bacterial strains by assessment of their minimum inhibitory concentration normally uses a standardized broth microdilution assay procedure developed more than 50 years ago. However, certain antibiotics require modified assay conditions in order to observe optimal activity. For example, daptomycin requires medium supplemented with Ca2+, and the lipoglycopeptides dalbavancin and oritavancin require Tween 80 to be added to the growth medium to prevent the depletion of free drug via adsorption to the plastic microplate. In this report, we examine systematically the effects of several different plate types on microdilution broth MIC values for a set of antibiotics against Gram-positive and Gram-negative bacteria, both in medium alone and in medium supplemented with the commonly used additives Tween 80, lysed horse blood, and 50% human serum. We observed very significant differences in measured MICs (up to 100-fold) for some lipophilic antibiotics, such as the Gram-positive lipoglycopeptide dalbavancin and the Gram-negative lipopeptide polymyxins, and found that non-specific binding plates can replace the need for surfactant additives. Microtiter plate types and any additives should be specified when reporting broth dilution MIC values, as results can vary dramatically for some classes of antibiotics.
引用
收藏
页数:17
相关论文
共 77 条
  • [1] In vitro Activity of Dalbavancin against Staphylococci Isolated in Istanbul, Turkey
    Aktas, Gulseren
    Derbentli, Sengul
    [J]. CHEMOTHERAPY, 2010, 56 (06) : 444 - 447
  • [2] ANDREWS J, 2006, DETERMINATION MINIMU
  • [3] Determination of minimum inhibitory concentrations
    Andrews, JM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 5 - 16
  • [4] Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters
    Arhin, Francis F.
    Tomfohrde, Karla
    Draghi, Deborah C.
    Aranza, Mohana
    Parr, Thomas R., Jr.
    Sahm, Daniel F.
    Moeck, Gregory
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 62 (01) : 92 - 95
  • [5] Effect of polysorbate 80 on oritavancin binding to plastic surfaces: Implications for susceptibility testing
    Arhin, Francis F.
    Sarmiento, Ingrid
    Belley, Adam
    McKay, Geoffrey A.
    Draghi, Deborah C.
    Grover, Parveen
    Sahm, Daniel F.
    Parr, Thomas R., Jr.
    Moeck, Gregory
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (05) : 1597 - 1603
  • [6] Assessment of Oritavancin Serum Protein Binding across Species
    Arhin, Francis F.
    Belley, Adam
    McKay, Geoffrey
    Beaulieu, Sylvain
    Sarmiento, Ingrid
    Parr, Thomas R., Jr.
    Moeck, Gregory
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) : 3481 - 3483
  • [7] A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli
    Baker, Kristin R.
    Jana, Bimal
    Franzyk, Henrik
    Guardabassi, Luca
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 5995 - 6002
  • [8] Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus
    Baltch, Aldona L.
    Ritz, William J.
    Bopp, Lawrence H.
    Michelsen, Phyllis B.
    Smith, Raymond P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1559 - 1562
  • [9] Plasma/Serum Protein Binding Determinations
    Banker, Michael J.
    Clark, Tracey H.
    [J]. CURRENT DRUG METABOLISM, 2008, 9 (09) : 854 - 859
  • [10] RAMOPLANIN SUSCEPTIBILITY TESTING CRITERIA
    BARRY, AL
    PFALLER, MA
    FUCHS, PC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) : 1932 - 1935